October 12th – 16th 2026
Inform Items
-
Digital Scribe Products – TGA have published the outcomes of their review of digital scribe products supplied in Australia. The review aimed to better understand the digital scribe products available in Australia, assess whether some functions of digital scribes may meet the definition of a medical device, and improve awareness of regulatory obligations and support compliance where needed. As part of the review, they have also updated the digital scribes guidance.
-
Updates to the UDI Hub – The UDI Hub has undergone a restructure to make information more accessible and tailored to different stages of the UDI journey. You can access the updated UDI Hub here: Unique Device Identification (UDI) hub | Therapeutic Goods Administration (TGA). Please note this restructure may break links you have previously saved.
-
Publication of Global Unique UDI Workshop Summary – The IMDRF UDI framework was developed to improve patient safety, support rapid device identification, enhance supply chain efficiency, reduce regulatory burden and enable global interoperability. Following feedback from regulators, industry, UDI issuing agencies and other stakeholders on the challenges of global UDI implementation, the IMDRF Management Committee requested a workshop be held to explore the key drivers of divergence and identify opportunities to improve alignment. The workshop brought together regulators, industry representatives, UDI issuing agencies and international organisations. You can find a summary of workshop discussions here: Global IMDRF UDI workshop – June 2026 | International Medical Device Regulators Forum.
-
Australian UDI Database (AusUDID) release – AusUDID Pre-Production and AusUDID Production environments were upgraded on 12 and 15 October 2026. The release included improved screen prompts when creating or managing UDI records using the AusUDID Online Portal, and an upgrade to .NET 10 to maintain ongoing Microsoft support as previous .NET versions reach end of support in November 2026. Full details of the upgrades are available here: AusUDID release notes.
-
TGA Industry Working Group – The communiqué from the TGA’s Industry Working Group meeting on 23 September 2026 is now available, and is attached to this email.
-
IMDRF Management Committee outcome statement – The IMDRF Management Committee met in Singapore on 17 to 18 September, and its outcome statement is now available. Decisions include welcoming Honduras (ARSA) and Thailand (Thai FDA) as Affiliate members, releasing draft N52 (Edition 3) Principles of Labelling for a 60-day public consultation, agreeing a new work item on Remedial Action Codes (Annex H) to describe industry remedial actions, publishing the UDI workshop synopsis with further targeted workshops to follow, and piloting an IMDRF training programme in September 2027.
Action Items
-
MTAA Committee Nominations Now Open – Nominations are open for 2027 industry representative positions across ten committees: Public Affairs, Reimbursement, Regulatory Affairs, Industry Development, Sustainability, Procurement, Code Authority, Code Monitoring, Women in MedTech and MedTech Conference. Nominate online at mtaa.awardsplatform.com by 5:00pm AEDT, Thursday 29 October. Confirmation emails will go to nominees’ Authorised Representatives in early November, the Board will approve membership on 9 December, and applicants will be notified by mid-December.
-
IMDRF Consultation: Draft Principles of Labelling for Medical Devices (N52, Edition 3) – IMDRF’s draft Edition 3 focuses on electronic labelling, adding definitions for e-label and eIFU and expecting a labelling risk analysis before electronic provision is chosen. It also sets expectations for eIFU access (including free paper copies on request) and extends e-labelling to software, lay-user devices, patient information and implant cards. Please add comments to the feedback spreadsheet by 6 November so MTAA can consolidate a response, or contact Laila (lwaheed@mtaa.org.au). IMDRF’s consultation closes 3 December.